The short answer
DSIP is a nine-residue peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, isolated from rabbit cerebral venous blood in 1977 and named for delta-wave EEG activity observed after administration. Despite the name, no DSIP gene, precursor protein or receptor has been characterised in the decades since.
Key facts
- Sequence
- Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Single-letter
- WAGGDASGE
- Length
- 9 residues (nonapeptide)
- Molecular weight
- 848.8 Da
- Molecular formula
- C35H48N10O15
- CAS number
- 62568-57-4
- PubChem CID
- 68816
- INN
- Emideltide
- Gene / receptor
- Neither identified
Where it came from
Schoenenberger, Monnier and colleagues in Basel electrically stimulated the thalamus of a sleeping rabbit, collected blood draining from its brain, and isolated a small peptide from it. Administered into the cerebral ventricles of awake rabbits, the fraction was reported to produce the slow delta-wave EEG pattern characteristic of deep sleep. The isolation was published in the Proceedings of the National Academy of Sciences in March 1977; the sequence followed in Pflügers Archiv in 1978.
The name is a hypothesis, not a finding
Delta sleep-inducing peptide describes what the discoverers believed they had found. That is normal for the era and not a criticism of the original work. It becomes a problem when the name is treated as a summary of established pharmacology, because the evidence behind it has never firmed up. A compound whose name asserts an effect will be read as having that effect, and readers rarely check whether the name was ever earned.
Research material referenced
DSIP 5mg, third-party HPLC tested
What was never established
This is the central fact about DSIP and it is routinely omitted. No DSIP gene has been isolated. No precursor protein has been identified. No receptor has been characterised. For a peptide proposed as an endogenous signalling molecule, that combination is remarkable. The usual route from isolation to accepted biology runs through exactly those three things, and DSIP has completed none of them in nearly fifty years.
How the field describes it
Kovalzon's 2006 review in the Journal of Neurochemistry is titled 'Delta sleep-inducing peptide (DSIP): a still unresolved riddle'. That is a fair summary of the literature's own assessment: a peptide with a substantial body of published work (roughly 519 indexed records) that has neither been confirmed as a sleep factor nor definitively dismissed.
A species detail
The peptide was isolated from rabbit. The relationship between the rabbit sequence and any human counterpart is part of what remains unresolved, and it matters because a peptide's endogenous role in one species does not establish one in another. Without an identified gene in any species, even this question stays open.
Regulatory position
DSIP holds no marketing authorisation from the MHRA, EMA or FDA. It carries an International Nonproprietary Name, emideltide, which reflects that a name was assigned rather than that a product was approved. It is supplied for laboratory research only.
Frequently asked questions
Does DSIP induce sleep?
The 1977 work reported delta-wave EEG activity in rabbits after administration. That an effect was observed in that experiment is not the same as the effect being established, and the subsequent literature has not resolved it.
Is DSIP a natural human peptide?
It was isolated from rabbit blood. No DSIP gene has been identified in any species, so its status as an endogenous peptide remains unconfirmed.
What is emideltide?
The International Nonproprietary Name assigned to DSIP. An INN is a naming decision, not an approval.
Is DSIP approved anywhere?
No. It holds no marketing authorisation and is supplied for laboratory research only.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedSchoenenberger GA et al., Characterization of a delta-EEG (sleep)-inducing peptide. PNAS 1977 (PMID 265572)pubmed.ncbi.nlm.nih.gov
- PubMedKovalzon VM, DSIP: a still unresolved riddle. J Neurochem 2006 (PMID 16539679)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Delta sleep-inducing peptide (CID 68816)pubchem.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More DSIP (Delta Sleep-Inducing Peptide) articles
- Does DSIP Actually Induce Sleep? What the Evidence ShowsDSIP is named for a sleep effect. The evidence has never firmed up: no gene, no receptor, and a literature its own reviewers call an unresolved riddle.
- How DSIP Was DiscoveredSchoenenberger and Monnier stimulated a sleeping rabbit's thalamus, collected the blood draining from its brain and isolated a peptide. The 1977 method.
- The Missing Biology: No Gene, No Precursor, No ReceptorFor an endogenous signalling peptide, DSIP is missing all three of the things that normally establish one. Why that absence matters more than any single study.
- What Delta Waves Are, and Why DSIP Is Named for ThemDelta waves are high-amplitude, low-frequency EEG activity below about 4 Hz, characteristic of deep non-REM sleep. What they measure and what they do not.
- DSIP Structure, Sequence and Physical PropertiesDSIP is WAGGDASGE, 9 residues, 848.8 Da, C35H48N10O15. An unusually acidic, glycine-rich sequence with a single aromatic residue and no cysteine.